However, this study is a retrospective study and is limited to parent-reported data
Some weeks may show little movement on the scales, which is normal
Refer to our comprehensive guide on foods to avoid on tirzepatide for specific recommendations
monthly or bi-monthly for maintenance Cost: Depends on dosage and whether combination treatment is included discussed at consultation
Metabolic indicators that may be associated with reduced GLP-1 activity include: Persistent elevated blood glucose levels , particularly postprandial (after-meal) hyperglycaemia Difficulty achieving or maintaining a healthy weight despite dietary efforts Increased appetite and reduced satiety after meals, leading to frequent snacking Diagnosis of type 2 diabetes or non-diabetic hyperglycaemia (NDH, sometimes called prediabetes), conditions where GLP-1 response is often blunted Features of metabolic syndrome , including central obesity, hypertension, and dyslipidaemia Individuals may also notice practical symptoms such as feeling hungry shortly after eating substantial meals, experiencing energy crashes following carbohydrate-rich foods, or finding portion control particularly challenging